SCHEMBL156244

SCHEMBL156244

C1CCCC2CCO[C]2CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7462821 1.00
SCHEMBL6322553 0.98
SCHEMBL19181540 0.91 CA1 (0.37)
SCHEMBL3506384 0.90
SCHEMBL25246055 0.88 CA1 (0.39)
SCHEMBL6234011 0.85
SCHEMBL25244924 0.83 CA1 (0.39)
SCHEMBL25356176 0.82 ALDH1A1 (0.32)
SCHEMBL25356175 0.80
SCHEMBL158642 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220002251-A1 HUMAN TLR8-SELECTIVE AGONISTS UNIVERSITY OF KANSAS (US) 2022-01-06 US disclosed
US-11130736-B2 Human TLR8-selective agonists UNIVERSITY OF KANSAS (US) 2021-09-28 US disclosed
US-20200377497-A1 NONTOXIC COMPOUNDS FOR THE TREATMENT AND PREVENTION OF HERPESVIRUS INFECTIONS THE PENN STATE RESEARCH FOUNDATION 2020-12-03 US disclosed
EP-3337481-B1 QUINOLINE-2-AMINE DERIVATIVES AS HUMAN TLR8-SELECTIVE AGONISTS FOR INCREASING IMMUNE RESPONSE UNIV KANSAS (US) 2020-11-11 EP disclosed
US-10781203-B2 Nontoxic compounds for the treatment and prevention of herpesvirus infections THE PENN STATE RESEARCH FOUNDATION (US) 2020-09-22 US disclosed
US-20190241553-A1 Nontoxic compounds for the treatment and prevention of herpesvirus infections THE PENN STATE RESEARCH FOUNDATION (US) 2019-08-08 US disclosed
US-20180258045-A1 HUMAN TLR8-SELECTIVE AGONISTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-09-13 US disclosed
EP-3337481-A1 HUMAN TLR8-SELECTIVE AGONISTS The University of Kansas (US) 2018-06-27 EP disclosed
WO-2018017853-A1 NONTOXIC COMPOUNDS FOR THE TREATMENT AND PREVENTION OF HERPESVIRUS INFECTIONS THE PENN STATE RESEARCH FOUNDATION (US) 2018-01-25 WO disclosed
US-9676818-B2 Toll-like receptor 2-agonistic lipopeptides, and method of making the same UNIVERSITY OF KANSAS (US) 2017-06-13 US disclosed
WO-2017034986-A1 HUMAN TLR8-SELECTIVE AGONISTS UNIVERSITY OF KANSAS (US) 2017-03-02 WO disclosed
US-20150337009-A1 TOLL-LIKE RECEPTOR 2-AGONISTIC LIPOPEPTIDES, AND METHOD OF MAKING THE SAME UNIVERSITY OF KANSAS 2015-11-26 US disclosed
WO-2014113634-A1 TOLL-LIKE RECEPTOR 2-AGONISTIC LIPOPEPTIDES, AND METHOD OF MAKING THE SAME UNIVERSITY OF KANSAS (US) 2014-07-24 WO disclosed
US-20140018566-A1 PALLADIUM(II)-CATALYZED SELECTIVE FLUORINATION OF BENZOIC ACIDS AND DERIVATIVES THE SCRIPPS RESEARCH INSTITUTE (US) 2014-01-16 US disclosed
WO-2012088402-A1 SYNTHESIS OF CONOLIDINE AND DISCOVERY OF A POTENT NON-OPIOID ANALGESIC FOR PAIN THE SCRIPPS RESEARCH INSTITUTE (US) 2012-06-28 WO disclosed
US-20120059179-A1 PALLADIUM-CATALYZED ORTHO-FLUORINATION The Scripps Research Insitiute (US) 2012-03-08 US disclosed
EP-2414317-A2 PALLADIUM-CATALYZED ORTHO-FLUORINATION The Scripps Research Institute (US) 2012-02-08 EP disclosed
WO-2010115098-A2 PALLADIUM-CATALYZED ORTHO-FLUORINATION THE SCRIPPS RESEARCH INSTITUTE (US) 2010-10-07 WO disclosed